Adriana Carrillo Mendoza

Directora Medica Desarrollo Nuevos Negocios at Grupo Farma
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Bogota, D.C., Capital District, Colombia, CO
Languages
  • Ingles Full professional proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Pedro Rugeles

Adriana, se ´preocupa por entregar el mejor servicio al cliente tanto interno como externo, con altos niveles de calidad, es una persona transparente, entusiasta y estudiosa. Buena compañera y Amiga. Persona Integra.

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Presencia ejecutiva para mujeres
    LinkedIn
    Feb, 2022
    - Nov, 2024

Experience

  • Grupo Farma
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Directora Medica Desarrollo Nuevos Negocios
      • Nov 2022 - Present

  • Clever Leaves
    • United States
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Senior Medical Manager
      • Mar 2020 - Nov 2022

      -Medical Advice to Pharmaceutical Companies on the development and research of cannabinoid based formulations for chronic pain and refractory epilepsy.-Implementation of strategies for cannabinoid based formulations access to institutions at nationallevel.-Strategic support in submission of cannabinoid based products to regulatory agencies in Latin America.-Development and execution of medical programs for cananbinoids prescription at national and Latin American level. -Medical Advice to Pharmaceutical Companies on the development and research of cannabinoid based formulations for chronic pain and refractory epilepsy.-Implementation of strategies for cannabinoid based formulations access to institutions at nationallevel.-Strategic support in submission of cannabinoid based products to regulatory agencies in Latin America.-Development and execution of medical programs for cananbinoids prescription at national and Latin American level.

  • Stendhal Pharma
    • Mexico
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Regional Medical Manager
      • Feb 2017 - Feb 2020

  • Sanofi
    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Multiple Sclerosis Medical Manager LATAM Region
      • Jul 2015 - Jan 2017

      -Strategic support in the interaction with the ministries of health of the countries of the region for access to MS products-Design and implementation of Phase IV studies and participation in global Phase III studies.-PAG's engagement and implementation of patient programs in the region focused on patient centricity. -Strategic support in the interaction with the ministries of health of the countries of the region for access to MS products-Design and implementation of Phase IV studies and participation in global Phase III studies.-PAG's engagement and implementation of patient programs in the region focused on patient centricity.

  • Sanofi
    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Multiple Sclerosis Medical Manager
      • Jan 2013 - Apr 2015

      - Contributing in both, clinical and business development strategies for MS Business Unit.- KOL partnership.- Product launch- Support sale forces training for Latam- Support medical activities for launching MS products in Latam- Designing observational phase IV studies.- Develop educational medical activities involving several countries in the region.

    • Rare Diseases Medical Manager Peru Ecuador Colombia Region
      • Jul 2012 - Feb 2013

  • Merck Healthcare
    • Germany
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Biotechnology Medical Manager
      • May 2010 - May 2012

      Fertility, Endocrinology and Neurology (Multiple Sclerosis)Phase IV and Observational Studies.To Develop and to execute Continuing Medical Education activities.KOL Partnership. Fertility, Endocrinology and Neurology (Multiple Sclerosis)Phase IV and Observational Studies.To Develop and to execute Continuing Medical Education activities.KOL Partnership.

  • Merck Group
    • Germany
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Primary Care Medical Manager
      • Mar 2009 - Mar 2010

      Antiinfective and Primary Care Products.Pharmacovigilance. Antiinfective and Primary Care Products.Pharmacovigilance.

Education

  • Universidad del Rosario
    Epidemiology and Public health
    2011 - 2012
  • Universidad de La Sabana
    Medicine
    2001 - 2008

Community

You need to have a working account to view this content. Click here to join now